Open AccessRheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis
Author(s) -
Luca Quartuccio,
S. Salvin,
Marta Saracco,
Stefania Lombardi,
Martina Fabris,
Elisa Mansutti,
M. Maset,
Silvia Pellerito,
Serena De Vita
Publication year - 2011
Publication title -
reumatismo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.294
H-Index - 25
eISSN - 2240-2683
pISSN - 0048-7449
DOI - 10.4081/reumatismo.2009.182
Subject(s) - medicine , rheumatoid arthritis , rituximab , rheumatoid factor , immunology , tumor necrosis factor alpha , antibody
Predictors of response to biologics in rheumatoid arthritis (RA) is an important issue in the current era. Rituximab (RTX) has been demonstrated effective and safe in active RA, resistant to traditional or biologic DMARDs.